AstraZeneca has named David Goldstein as chief adviser to its move to build and make use of a database of 2 million whole genomes.
Desktop Genetics, Horizon Discovery and Vectalys have teamed up to develop custom-made CRISPR lenti-gRNA libraries.
Successful clinical trials require bringing together diverse data, drawing meaningful insights and acting on those quickly. Learn how one company did just that…
Illumina has agreed to comarket Dovetail Genomics’ genome assembly service, an offering that leverages short-read sequencers to deliver long-range information.
Tute Genomics is crowdfunding a DNA sequencing scheme. The campaign is aiming to raise $100,000 by offering whole genome sequencing for between $999 and $1,499.
A consortium of cancer centers has contracted HudsonAlpha Institute of Biotechnology to sequence 20,000 samples by 2019.
IDbyDNA has raised $9 million to develop its metagenomics analysis software and introduce clinical tests for infectious diseases.
Personal microbiome sequencing pioneer uBiome has lured ex-Genentech scientist Audrey Goddard away from Genomic Health to oversee its R&D activities.
OncoDNA has raised $8.6 million to develop IT platforms to support its oncology testing operation.
Repositive has introduced the full version of its online genomics data platform, which features 23 times as many data sets as the beta iteration.
The rise of genome sequencing has opened a new frontier for the issue that could drive divergence of the cancer care received by different races.